Jemal A,Tiwari RC,Murray T,Ghafoor A,Samuels A .2004 .A Cancer Journal for Clinicians, (. Cancer statistics, 54(1) : 8-29.
Kessenbrock K,Plaks V .2010 .Matrix metalloproteinases: regulators of the tumor microenvironment. Cell, 141(1) : 52-67.
Page-McCaw A,Ewald AJ .2007 .Matrix metalloproteinases and the regulation of tissue remodelling. Nature Reviews Molecular Cell Biology, 8(3) : 221-233.
Parks WC,Wilson CL,Lopez-Boado YS .2004 .Matrix metalloproteinases as modulators of inflammation and innate immunity. Nature Reviews Immunology, 4(8) : 617-629.
Nagase H,Visse R,Murphy G .2006 .Structure and function of matrix metalloproteinases and TIMPs. , 69(3) : 562-573.
Roy R,Yang J,Moses MA .2009 .Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. Journal of Clinical Oncology, 27(31) : 5287-5297.
Liotta LA,Tryggvason K,Garbisa S,Hart I,Foltz CM .1980 .Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature, 284(5751) : 67-68.
Cauwe B,Van den Steen PE,Opdenakker G. .2007 .The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Critical Reviews in Biochemistry and Molecular Biology, 42(3) : 113-185.
Egeblad M,Z M .2002 .New functions for the matrix metalloproteinases in cancer progression. Nature Reviews Cancer, 2(3) : 161-174.
Tauro M,Lynch CC .2018 .Cutting to the Chase: How Matrix Metalloproteinase-2 Activity Controls Breast-Cancer-toBone Metastasis. Cancers (Basel), 10(6) : 185.
Fu Z,Xu S,Xu Y,Ma J,Li J .2015 .The expression of tumorderived and stromal-derived matrix metalloproteinase 2 predicted prognosis of ovarian cancer. International Journal of Gynecological Cancer, 25(3) : 356-362.
Shen W,Xi H,Wei B,Chen L .2014 .The prognostic role of matrix metalloproteinase 2 in gastric cancer: a systematic review with meta-analysis. Journal of Cancer Research and Clinical Oncology, 140(6) : 1003-1009.
Lionta E,Spyrou G,Vassilatis DK .2014 .Structurebased virtual screening for drug discovery: principles, applications and recent advances. Current Topics in Medicinal Chemistry, 14(16) : 1923-1938.
Zhu H,Zhang Y,Li W,Huang N. .2022 .A Comprehensive Survey of Prospective Structure-Based Virtual Screening for Early Drug Discovery in the Past Fifteen Years. International Journal of Molecular Sciences, 23(24) : 15961.
Jang C,Yadav DK,Subedi L,Venkatesan R,Venkanna A .2018 .Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay. Scientific Reports, 8(1) : 14921.
Sharma V,Jaiswal PK,Kumar S,Mathur M,Swami AK .2018 .Discovery of Aporphine Analogues as Potential Antiplatelet and Antioxidant Agents: Design, Synthesis, StructureActivity Relationships, Biological Evaluations, and in silico Molecular Docking Studies. ChemMedChem, 13(17) : 1817-1832.
Dallakyan S,Olson AJ .2015 .Small-molecule library screening by docking with PyRx. Methods in Molecular Biology, 1263 : 243-250.
Reddy RA,Sai Varshini M,Kumar RS .2023 .Matrix Metalloproteinase-2 (MMP-2): As an Essential Factor in Cancer Progression. Recent Patents on Anti-Cancer Drug Discovery, 10 : .
Chien MH,Lin CW,Cheng CW,Wen YC,Yang SF .2013 .Matrix metalloproteinase-2 as a target for head and neck cancer therapy. Expert Opinion on Therapeutic Targets, 17(2) : 203-216.
Kamal MA,I JH MA,R SA MA,M SH MA .2023 .Insights from the molecular docking analysis of EGFR antagonists. , 19(3) : 260-265.
Sayed Murad HA,Alqahtani M MR,SM M MR,Alghamdi B SR,S B SR .2023 .Molecular docking analysis of AGTR1 antagonists. , 19(3) : 284-289.
Elaimi A,Hanadi MB,Almutairi A,Alniwaider RA,Abulkaliq MA .2023 .Insights from the molecular docking analysis of GRP78 with natural compound inhibitors in the management of cancers. , 19(1) : 39-42.
Alsharif I JH,Aljadani FH,Fahad Alabbas M,Faqihi I,MS I .2023 .Molecular docking analysis of KRAS inhibitors for cancer management. Bioinformation, 19(4) : 411-416.
Choudhari AS,Mandave PC,Deshpande M,Ranjekar P,Prakash O. .2019 .Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice. , 10 : 1614.
George BP,Chandran R,Abrahamse H,Antioxidants H .2021 .To read the copy of this license please visit: https://creativecommons. , 10(9) : 1455.